API

Active Pharmaceutical Ingredients (APIs) are combined with excipients (inactive substances) to make drugs.  Here you will find content about the development, manufacturing, analysis and regulation of pharmaceutical APIs.

Articles

Excipient-based strategies to harness complex therapeutics

Though excipients are a necessary drug component that can often be taken for granted, the ever-changing pharma landscape is always pushing us to shift our perspectives.
Screen Shot 2023 09 06 At 11 17 20 Am
Screen Shot 2023 09 06 At 11 17 20 Am
Screen Shot 2023 09 06 At 11 17 20 Am
Screen Shot 2023 09 06 At 11 17 20 Am
Screen Shot 2023 09 06 At 11 17 20 Am

Bridging the gap between R&D and GMP

Companies prioritizing optimized synthetic routes, stable API forms, and verified analytical tools set the stage for phase I clinical manufacturing success
PM2208-HERO-575x327-Development
PM2208-HERO-575x327-Development
PM2208-HERO-575x327-Development
PM2208-HERO-575x327-Development
PM2208-HERO-575x327-Development

Toward a collaborative pharma ecosystem

A new biomanufacturing era demands that suppliers and manufacturers partner to efficiently bring new therapies to market
final-may
final-may
final-may
final-may
final-may

Reevaluating pharma packaging priorities

Supply chain challenges and industry trends are spurring new business strategies
india
india
india
india
india

Global Dose: Focus on India

The world's leader of generic drug production looks towards new horizons in pharma
PM2101-Predictions-Logo
PM2101-Predictions-Logo
PM2101-Predictions-Logo
PM2101-Predictions-Logo
PM2101-Predictions-Logo

Top pharma industry predictions for 2021

In many ways, the beginning of 2021 isn’t just one of the most welcome New Years of the modern era — it could also be a turning point between the pre-COVID and post-COVID worlds...
powder
powder
powder
powder
powder

The case for nanoparticles

Leveraging new powder technologies to manufacture personalized medicines
shutterstock-1734037067
shutterstock-1734037067
shutterstock-1734037067
shutterstock-1734037067
shutterstock-1734037067

Manufactured patriotism

The government wants to reshore generics, but the drug industry isn’t celebrating
lab
lab
lab
lab
lab

Harnessing lab power on the pharma plant floor

Technologies accelerating the verification process for raw materials
PM2009-HERO-880x500-CoverStory2
PM2009-HERO-880x500-CoverStory2
PM2009-HERO-880x500-CoverStory2
PM2009-HERO-880x500-CoverStory2
PM2009-HERO-880x500-CoverStory2

Bring it home

Inside the movement to put generic drug production back on America's shores
ships
ships
ships
ships
ships

The growing benefits to reshoring pharma operations

The need to explore the diversification of U.S. pharmaceutical supply chains and the feasibility of relocation has never been higher.
Screen-Shot-2020-04-20-at-1.23.32-PM
Screen-Shot-2020-04-20-at-1.23.32-PM
Screen-Shot-2020-04-20-at-1.23.32-PM
Screen-Shot-2020-04-20-at-1.23.32-PM
Screen-Shot-2020-04-20-at-1.23.32-PM

Driving excipient innovation

Overcoming regulatory constraints surrounding novel excipients can elevate the entire industry
Thermo-FIgure1
Thermo-FIgure1
Thermo-FIgure1
Thermo-FIgure1
Thermo-FIgure1

Innovation in excipient analysis

How modern techniques are helping pharma overcome excipient analysis hurdles
PM1912-Syringe-Butterfly
PM1912-Syringe-Butterfly
PM1912-Syringe-Butterfly
PM1912-Syringe-Butterfly
PM1912-Syringe-Butterfly

Carcinogenic butterflies

Recent recalls may alter the path of quality in pharma
PM1912-AwardHero-880x500
PM1912-AwardHero-880x500
PM1912-AwardHero-880x500
PM1912-AwardHero-880x500
PM1912-AwardHero-880x500

The recall effect

How the blood pressure debacle is rippling through the industry